BD (company)
Trade name | BD |
|---|---|
| Company type | Public |
Traded as |
|
| Industry | Medical equipment, Consulting |
| Founded | 1897 in East Rutherford, New Jersey |
| Founders |
|
| Headquarters | , U.S. |
Area served | Worldwide |
Key people |
|
| Revenue | US$20.248 billion (Fiscal Year Ended September 30, 2021) |
| US$2.799 billion (Fiscal Year Ended September 30, 2021) | |
Net income | US$2.002 billion (Fiscal Year Ended September 30, 2021) |
| Total assets | US$53.866 billion (Fiscal Year Ended September 30, 2021) |
| Total equity | US$23.677 billion (Fiscal Year Ended September 30, 2021) |
Number of employees | ≈ 75,000 (September 2021) |
| Divisions |
|
| Website | bd |
| Footnotes / references Financials as of September 30, 2021 | |
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
BD is ranked #177 in the 2021 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2020.
In October 2014, the company agreed to acquire CareFusion for a price of US$12.2 billion in cash and stock.
In April 2017, C. R. Bard announced that it would be acquired by Becton, Dickinson and Company (BD). The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.